Study: NCT05489211

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil
Description: Administered as an IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil
Description: Administered as an IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Volrustomig
Description: Administered as an IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Administered as an IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Administered as an IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin LV
Description: Administered as an IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Administered as an IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Administered as an IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rilvegostomig
Description: Administered as an IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone/ prednisolone
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Administered as an IV